Kane Biotech (KNE) Stock Price Down 11.1%

Kane Biotech Inc (CVE:KNE)’s share price was down 11.1% during mid-day trading on Wednesday . The company traded as low as C$0.08 and last traded at C$0.08. Approximately 128,200 shares changed hands during mid-day trading, an increase of 119% from the average daily volume of 58,540 shares. The stock had previously closed at C$0.09.

Kane Biotech (CVE:KNE) last issued its earnings results on Tuesday, August 21st. The company reported C($0.01) earnings per share (EPS) for the quarter. The firm had revenue of C$0.10 million during the quarter. Kane Biotech had a negative return on equity of 172.74% and a negative net margin of 1,545.33%.

Kane Biotech Company Profile (CVE:KNE)

Kane Biotech Inc, a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms worldwide. It develops wound care solutions under the DispersinB trademark; medical device coatings under the Aledex trademark; shampoo for dogs, cats, and horses under the Alosera trademark; and pet oral care solutions under the StrixNB and bluestem trademarks.

Featured Story: What are the Different Types of Leveraged Buyouts?

Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply